Viability of developing CETP inhibitors. - Wikidata - wikimedia - TriplyDB

Viability of developing CETP inhibitors.

Viability of developing CETP inhibitors.

http://www.wikidata.org/entity/Q37165682

about

The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?Is high HDL cholesterol always good?

P2860

Q33993233-EA3BA69E-C5DD-4312-8B58-A17AF66AA216 Q37351659-44817673-DCDC-4B8D-8846-7F178A2BAB7D

P2860

Viability of developing CETP inhibitors.

http://www.wikidata.org/entity/Q37165682

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Viability of developing CETP inhibitors.

@en

Viability of developing CETP inhibitors.

@nl

type

label

Viability of developing CETP inhibitors.

@en

Viability of developing CETP inhibitors.

@nl

prefLabel

Viability of developing CETP inhibitors.

@en

Viability of developing CETP inhibitors.

@nl

P1433

Q37165682-48420DBB-91E3-406D-9169-AA99E017D186

P1476

Q37165682-B9EC68CF-CDBF-47B1-9B04-ECD4318C210F

P2093

Q37165682-5A7740A2-5C40-40AA-813D-85A36EDEB7DD

Q37165682-C56D4623-E0BC-4904-97B2-DEBCA06FED8E

P2860

Q37165682-0534D483-7935-4F4D-A8F1-A4E2B5025893

Q37165682-05529C5B-C3F3-4464-9644-E084B3B81F94

Q37165682-1708FFD3-0A2E-4255-B8D1-BDC1C9436611

Q37165682-1E0C8B0D-B023-4544-8C90-402E68BED1C0

Q37165682-29D8BCBE-8B10-427B-A23D-8957A58BF9C8

Q37165682-2BFF941B-DDBD-43B0-9EBC-9D82A81642E8

Q37165682-2C886591-5615-4307-A297-B366BD931833

Q37165682-2D50F9E2-A1C1-4D89-80BA-48709713B98E

Q37165682-2E43D477-0147-4860-B6F2-F9242FC16A9C

Q37165682-34E73AD6-1612-4338-91D3-2486DB6FE665

P304

Q37165682-6A5898C7-791F-4A40-A2BC-9BA99BB8DE59

P31

Q37165682-78881883-BD1A-4C4A-8367-F69C14EEBA12

P356

Q37165682-DF02E222-1626-4380-80BD-B595A680B1C8

P433

Q37165682-D6E64FE2-E1BF-47DC-9AF8-B885BEDC01DA

P478

Q37165682-1CD91697-D6C8-4CC3-801F-DDB4FEECF5C5

P577

Q37165682-C41D5AC9-1507-4EB7-B39B-50ECD2A39944

P5875

Q37165682-A40DD2DB-DAF7-4F09-BAF8-5286118DA7C6

P698

Q37165682-4A07D690-CACB-49C5-808D-A7F68F6A05FF

P356

J.1527-3466.2008.00049.X

P1433

Cardiovascular Therapeutics

P1476

Viability of developing CETP inhibitors.

@en

P2093

Cesare R Sirtori

http://www.w3.org/2001/XMLSchema#string

Giuliana Mombelli

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning and sequencing of human cholesteryl ester transfer protein cDNA

HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway

Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins

Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels

Unique lipoprotein phenotype and genotype associated with exceptional longevity

Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response study

Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial

Description of the torcetrapib series of cholesteryl ester transfer protein inhibitors, including mechanism of action

Effect of torcetrapib on the progression of coronary atherosclerosis

Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia

P304

135-146

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1527-3466.2008.00049.X

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5365719

http://www.w3.org/2001/XMLSchema#string

P698

18485135

http://www.w3.org/2001/XMLSchema#string